CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 113 filers reported holding CARA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $10 | -72.2% | 40 | 0.0% | 0.00% | – |
| Q1 2024 | $36 | +20.0% | 40 | 0.0% | 0.00% | – |
| Q4 2023 | $30 | -76.4% | 40 | -47.4% | 0.00% | – |
| Q3 2023 | $127 | -55.4% | 76 | -99.7% | 0.00% | -100.0% |
| Q4 2022 | $285 | -99.9% | 26,629 | -21.5% | 0.00% | -33.3% |
| Q3 2022 | $333,000 | -3.5% | 33,909 | -5.3% | 0.00% | 0.0% |
| Q2 2022 | $345,000 | -25.2% | 35,809 | +1.5% | 0.00% | 0.0% |
| Q1 2022 | $461,000 | +7.5% | 35,284 | -3.0% | 0.00% | 0.0% |
| Q4 2021 | $429,000 | -11.7% | 36,379 | -4.9% | 0.00% | 0.0% |
| Q3 2021 | $486,000 | -2.8% | 38,258 | -5.1% | 0.00% | 0.0% |
| Q2 2021 | $500,000 | – | 40,313 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,647,473 | $24,780,000 | 2.96% |
| Chescapmanager LLC | 1,160,392 | $10,861,000 | 2.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,333,000 | $12,477,000 | 1.60% |
| Altium Capital Management LP | 193,000 | $1,806,000 | 0.66% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,700,230 | $15,914,000 | 0.44% |
| ALPINE WOODS CAPITAL INVESTORS, LLC | 171,423 | $1,605,000 | 0.22% |
| Lisanti Capital Growth, LLC | 159,225 | $1,490,000 | 0.20% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 72,529 | $679,000 | 0.15% |
| PINNACLE ASSOCIATES LTD | 705,367 | $6,602,000 | 0.15% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,500,000 | $23,400,000 | 0.13% |